Kamada Ltd. (KMDA) Revenue History
Annual and quarterly revenue from 2008 to present
KMDA Revenue Over Time (2008–2025)
KMDA Revenue Growth History
13 of 17 years with positive growth- FY2008 revenue growth
- N/A
- FY2009 revenue growth
- -1.5%
- FY2010 revenue growth
- +142.2%
- FY2011 revenue growth
- +54.2%
- FY2012 revenue growth
- +30.0%
- FY2013 revenue growth
- -2.8%
- FY2014 revenue growth
- +1.8%
- FY2015 revenue growth
- -2.5%
- FY2016 revenue growth
- +10.5%
- FY2017 revenue growth
- +32.7%
- FY2018 revenue growth
- +11.3%
- FY2019 revenue growth
- +11.1%
- FY2020 revenue growth
- +4.8%
- FY2021 revenue growth
- -22.2%
- FY2022 revenue growth
- +24.8%
- FY2023 revenue growth
- +10.2%
- FY2024 revenue growth
- +12.9%
- FY2025 revenue growth
- +12.1%
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $45.2M | +2.8% |
| Q4 2025 | $44.7M | +14.5% |
| Q3 2025 | $47.0M | +12.6% |
| Q2 2025 | $44.8M | +5.4% |
| Q1 2025 | $44.0M | +16.6% |
| Q4 2024 | $39.0M | +7.1% |
| Q3 2024 | $41.7M | +10.0% |
| Q2 2024 | $42.5M | +13.4% |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2025)
KMDA's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
KMDA Revenue Analysis (2008–2025)
Current Revenue & Growth
As of June 23, 2026, Kamada Ltd. (KMDA) generated trailing twelve-month (TTM) revenue of $181.7 million, reflecting modest growth of +2.8% year-over-year. The most recent quarter (Q1 2026) recorded $45.2 million in revenue, up 1.3% sequentially.
Historical Growth Trajectory
KMDA's 5-year compound annual growth rate (CAGR) stands at +6.3%, indicating steady revenue expansion. The 3-year CAGR of +11.7% exceeds the 5-year average, indicating an acceleration in the most recent period. Kamada Ltd.'s highest annual revenue of $180.5 million was recorded in 2025, an all-time high.
Revenue by Segment
KMDA's revenue is primarily driven by Distribution Member (100%). With over half of revenue concentrated in Distribution Member, the company has a focused business model while developing other growth vectors.
Peer Comparison
Compared to Healthcare sector peers — including ADMA (+11.0% YoY), GRFS (+1.0% YoY), and BIO (+1.9% YoY) — KMDA has underperformed the peer group in revenue growth. Compare KMDA vs ADMA →
KMDA Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| KMDACurrent | $182M | +2.8% | +6.3% | 14.5% | |
 ADMA | $510M | +11.0% | +64.6% | 37.5% | |
 GRFS | $7.2B | +1.0% | +6.2% | 16.4% | |
 BIO | $2.6B | +1.9% | +0.3% | 10.5% | |
 RARE | $673M | +13.3% | +19.9% | -79.5% |
KMDA Historical Revenue Data (2008–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $180.5M | +12.1% | $76.4M | 42.3% | $26.2M | 14.5% |
| 2024 | $161.0M | +12.9% | $70.0M | 43.5% | $20.1M | 12.5% |
| 2023 | $142.5M | +10.2% | $55.5M | 38.9% | $10.1M | 7.1% |
| 2022 | $129.3M | +24.8% | $46.7M | 36.1% | $4.5M | 3.5% |
| 2021 | $103.6M | -22.2% | $30.3M | 29.3% | $-696,000 | -0.7% |
| 2020 | $133.2M | +4.8% | $47.6M | 35.7% | $19.2M | 14.4% |
| 2019 | $127.2M | +11.1% | $49.7M | 39.1% | $22.8M | 17.9% |
| 2018 | $114.5M | +11.3% | $41.5M | 36.2% | $19.3M | 16.8% |
| 2017 | $102.8M | +32.7% | $32.1M | 31.2% | $7.4M | 7.2% |
| 2016 | $77.5M | +10.5% | $21.6M | 27.9% | $-5,841,000 | -7.5% |
| 2015 | $70.1M | -2.5% | $16.0M | 22.8% | $-11,424,000 | -16.3% |
| 2014 | $71.9M | +1.8% | $15.6M | 21.7% | $-10,902,000 | -15.2% |
| 2013 | $70.6M | -2.8% | $26.4M | 37.4% | $3.7M | 5.2% |
| 2012 | $72.7M | +30.0% | $22.7M | 31.2% | $4.2M | 5.8% |
| 2011 | $55.9M | +54.2% | $15.7M | 28.1% | $-2,317,394 | -4.1% |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
18+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
KMDA — Frequently Asked Questions
Quick answers to the most common questions about buying KMDA stock.
Is KMDA's revenue growth accelerating or slowing?
KMDA revenue growth is slowing. TTM revenue is $182M, up +2.8% year-over-year — below the 5-year CAGR of +6.3%. The deceleration suggests maturing end-markets or increased competition.
What is KMDA's revenue history from 2008 to 2026?
Kamada Ltd. (KMDA) revenue history spans 2008 to 2026. TTM revenue as of 2026 is $182M, growing at +2.8% YoY. The 5-year CAGR is +6.3%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is KMDA's long-term revenue growth rate (CAGR)?
Kamada Ltd.'s 5-year revenue CAGR of +6.3% reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of +2.8% is below this long-term average. CAGR is the most reliable measure of sustained revenue momentum for KMDA.
Why does KMDA's quarterly revenue fluctuate?
KMDA quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Kamada Ltd.'s revenue data from 2008 to 2026 shows full historical quarterly detail on this page.
How is KMDA's revenue distributed by segment?
KMDA reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does KMDA's revenue compare to industry peers?
Kamada Ltd. (KMDA) with TTM revenue of $182M and +2.8% YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.